Clinical and laboratory effects of recombinant human activated protein C in the treatment of a patient with sepsis-induced multiple organ failure. [electronic resource]
Producer: 20040422Description: 259-63 p. digitalISSN:- 0049-3848
- Adult
- Anti-Bacterial Agents
- Anticoagulants -- pharmacology
- Combined Modality Therapy
- Disseminated Intravascular Coagulation -- prevention & control
- Drainage
- Drug Evaluation
- Drug Therapy, Combination -- therapeutic use
- Female
- Humans
- Knee Joint -- surgery
- Multiple Organ Failure -- blood
- Postoperative Complications -- blood
- Protein C -- pharmacology
- Recombinant Proteins -- pharmacology
- Retropharyngeal Abscess -- drug therapy
- Systemic Inflammatory Response Syndrome -- complications
- Urinary Catheterization -- adverse effects
- Urinary Tract Infections -- complications
No physical items for this record
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.